Anthony Palumbo and Charles Goulding analyze Boston Scientific’s US$14.5 billion acquisition of Penumbra, showing how additive manufacturing can accelerate thrombectomy and neurovascular innovation through rapid device prototyping, micro-precision component development, production tooling, and the use of 3D printed vascular models for testing and physician training.